cp wire

CP Wire Articles

Ardelyx Announces $50 Million Stock Offering

Ardelyx, Inc. (Nasdaq: ARDX) announced on 5/22/18 the pricing of an underwritten public offering of 12,500,000 shares of its common stock at a public offering price of $4.00 per share, before... read more

Tue, 05/22/18 - 08:57 pm
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
  • Elayta currently in phase II testing
  • Has been granted fast track status by the FDA
  • Phase I/IIa trials showed Elayta  significantly reduced concentrations of synapse damage... read more
Tue, 05/22/18 - 11:00 am
FDA Clears IND for CytomX's CX-2029, a CD71-Directed Probody Therapeutic



  • Co-developing drug with Abbvie
  • CytomX is eligible to receive up to $470 million in development, regulatory and commercial milestones
  • CD71 is a highly... read more
Tue, 05/22/18 - 08:41 am
Pfizer Begins a Phase 1/2 Study to Evaluate RSV Vaccine

Pfizer Inc. (NYSE:PFE) announced on 5/22/18 that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common... read more

Tue, 05/22/18 - 08:30 am
Latest Phase 2 Data Shows Pamrevlumab Reduces Rate of Progression in Idiopathic Pulmonary Fibrosis

FibroGen, Inc. (NASDAQ:FGEN), announced on 5/21/18 that updated results from the company’s randomized, double-blind, placebo-controlled Phase 2b PRAISE study of pamrevlumab in patients with... read more

Mon, 05/21/18 - 10:44 pm

Pages